| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-07 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.22 | 8e-05 |